EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)

Steven Vernino, Steve Hopkins, Meredith Bryarly, Roberto S Hernandez, Amber Salter

Clinical Autonomic Research · 2024

DOI: 10.1007/s10286-024-01020-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Autonomic Research, 2024. Verfasst von Steven Vernino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA. Steven.Vernino@UTSouthwestern.edu. Hauptthemen laut MEDLINE: Autoimmune Diseases, Postural Orthostatic Tachycardia Syndrome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Dysautonomia International, Sjögren's Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study assesses response to intravenous immunoglobulin (IVIG) in presumed autoimmune postural orthostatic tachycardia syndrome (POTS). BACKGROUND: POTS may be associated with autoimmune disorders, serum autoantibodies, or recent infection. Uncontrolled case studies suggest that IVIG is beneficial for treating autoimmune POTS. No previous randomized controlled trials have been conducted. METHODS: This single-site randomized controlled trial compared IVIG with intravenous albumin infusions. Albumin comparator ensured blinding and control for effects of volume expansion. Eligible patients with POTS had COMPASS-31 total weighted score ≥ 40 and met predetermined criteria suggesting autoimmunity. Over 12 weeks, participants received eight infusions (0.4 gm/kg each). Four infusions were given weekly followed by four infusions every other week. Primary outcome measure was improvement in COMPASS-31 2 weeks after final infusion. RESULTS: A total of 50 participants consented; 30 met inclusion criteria and received study drug (16 IVIG and 14 albumin; 29 female). Group baseline characteristics were well matched; 27 participants completed treatment protocol. Change in COMPASS-31 did not differ between groups (median change [IQR]; IVIG: -5.5 [-23.3, 2.5] versus albumin: -10.6 [-14.1, -4.7]; p-value = 0.629). The IVIG group had a higher response rate (46.7% versus 38.5%), but this was not statistically significant. Adverse events were common but usually mild and did not differ between treatment groups. CONCLUSIONS: This small randomized controlled trial of IVIG in POTS found no statistical difference in response compared with albumin infusion. Both groups showed improvement possibly related to volume expansion or other effects obscuring group differences. These findings inform development of future immunomodulatory clinical trials in POTS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesPostural Orthostatic Tachycardia SyndromeFemaleHumansAlbuminsAutoimmunityImmunoglobulins, Intravenous

Stichwörter der Autor:innen

AlbuminClinical trialDysautonomiaIVIGPostural orthostatic tachycardia syndrome (POTS)

Substanzen

AlbuminsImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA. Steven.Vernino@UTSouthwestern.edu.
  • Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.

Förderung

  • Dysautonomia International
  • Sjögren's Foundation

Zitieren

APA

Vernino, S., Hopkins, S., Bryarly, M., Hernandez, R. S., & Salter, A. (2024). Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND). Clinical Autonomic Research. https://doi.org/10.1007/s10286-024-01020-9

Vancouver

Vernino S, Hopkins S, Bryarly M, Hernandez RS, Salter A. Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND). Clinical Autonomic Research. 2024. doi:10.1007/s10286-024-01020-9

BibTeX
@article{Vernino2024,
  author = {Vernino, Steven and Hopkins, Steve and Bryarly, Meredith and Hernandez, Roberto S and Salter, Amber},
  title = {Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)},
  journal = {Clinical Autonomic Research},
  year = {2024},
  doi = {10.1007/s10286-024-01020-9}
}
Kostenlos starten →